Selective alteration of personality and social behavior by serotonergic intervention.

OBJECTIVE The authors sought to test the causal hypothesis that serotonergic function modulates aspects of the normal spectrum of individual differences in affective experience and social behavior in humans. METHOD A selective serotonin reuptake inhibitor (SSRI), paroxetine, 20 mg/day (N = 26), or placebo (N = 25) was administered to normal volunteers in a double-blind manner for 4 weeks, and personality variables and social behavior were assessed at baseline and at weeks 1 and 4 of treatment. RESULTS Relative to placebo, SSRI administration reduced focal indices of hostility through a more general decrease in negative affect, yet did not alter indices of positive affect. In addition, SSRI administration increased a behavioral index of social affiliation. Changes in both negative affect and affiliative behavior were significantly related to volunteers' plasma SSRI levels at the end of the experiment. CONCLUSIONS Central serotonergic function may modulate a dimension of normal personality characterized by reduced negative affective experience and increased affiliative behavior. SSRI administration has significant and detectable effects on these measures even in the absence of baseline clinical depression or other psychopathology.

[1]  T. Bouchard,et al.  Genes, environment, and personality. , 1994, Science.

[2]  W. Goodman,et al.  Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects , 1997, Biological Psychiatry.

[3]  J. Panksepp,et al.  Effects of fluoxetine on play dominance in juvenile rats , 1996 .

[4]  C. Robert Cloninger.  A systematic method for clinical description and classification of personality variants. A proposal. , 1987, Archives of general psychiatry.

[5]  C. Nemeroff,et al.  CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. , 1994, Archives of general psychiatry.

[6]  M. Linnoila,et al.  Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. , 1996, Archives of general psychiatry.

[7]  J. Harten.  Clinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors , 1993 .

[8]  D. Stoff,et al.  Aggression and Violence: Genetic, Neurobiological, and Biosocial Perspectives , 1996 .

[9]  M. Zuckerman.  Good and Bad Humors: Biochemical Bases of Personality and Its Disorders , 1995 .

[10]  J. Carlson,et al.  Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex , 1996, Brain Research.

[11]  R. Depue,et al.  Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. , 1994, Journal of personality and social psychology.

[12]  L. Siever,et al.  The serotonin system and aggressive personality disorder , 1993, International clinical psychopharmacology.

[13]  R. Fuller.  The Influence of Fluoxetine on Aggressive Behavior , 1996, Neuropsychopharmacology.

[14]  A. Tellegen.  Structures of Mood and Personality and Their Relevance to Assessing Anxiety, With an Emphasis on Self-Report , 2019, Anxiety and the Anxiety Disorders.

[15]  J. M. Digman.  PERSONALITY STRUCTURE: EMERGENCE OF THE FIVE-FACTOR MODEL , 1990 .

[16]  M. Brett,et al.  Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[17]  Cloninger Cr.  A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .

[18]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[19]  John B. Willett,et al.  Understanding correlates of change by modeling individual differences in growth , 1985 .

[20]  Paul T. Costa,et al.  Set like plaster? Evidence for the stability of adult personality. , 1994 .

[21]  E. Coccaro,et al.  Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain‐behavior relationship , 1992, International clinical psychopharmacology.

[22]  Streichenwein Sm,et al.  Am J Psychiatry , 1996 .

[23]  M. Linnoila,et al.  Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates. , 1995, The American journal of psychiatry.

[24]  A. Buss,et al.  An inventory for assessing different kinds of hostility. , 1957, Journal of consulting psychology.

[25]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[26]  M. Raleigh,et al.  Dominant social status facilitates the behavioral effects of serotonergic agonists , 1985, Brain Research.

[27]  Michael J. Raleigh,et al.  Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys , 1991, Brain Research.

[28]  M. Linnoila,et al.  Stability of Interindividual Differences in Serotonin Function and Its Relationship to Severe Aggression and Competent Social Behavior in Rhesus Macaque Females , 1996, Neuropsychopharmacology.

[29]  S. Koslow,et al.  Drug-Induced Actions on Brain Neurotransmitter Systems and Changes in the Behaviors and Emotions of Depressed Patients , 1994, Neuropsychopharmacology.

[30]  Peggy Dean,et al.  Mood Response to Acute Tryptophan Depletion in Healthy Volunteers: Sex Differences and Temporal Stability , 1996, Neuropsychopharmacology.

[31]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[32]  J. Hyttel.  Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) , 1994, International clinical psychopharmacology.

[33]  E. Coccaro,et al.  Neurotransmitter correlates of impulsive aggression. , 1996 .